22 results
Pharmacologic Treatments of Chronic Hypertension in Pregnancy
Central alpha-agonists
 - Methyldopa
 - Clonidine
Combined alpha- and beta-blocker
 -
Pharmacologic Treatments ... - Nifedipine (long-acting ... Hypertension #Pregnancy #Management ... #Treatment #Pharmacology ... #HTN #Table #Drugs
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
tamponade, Pulmonary embolism ... pharmacology ... inopressors #diagnosis ... #management #comparison ... #table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... highlighted circle= clinical ... smfarmhosp_smfh #Drugs ... #COVID19 #Pharmacology ... #Table #Management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... and Management ... Lung Abscess - Clinical ... Abscess Management ... #treatment #diagnosis
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
Failure (ACLF) Clinical ... months without treatment ... Brain Failure Lung ... Hepatitis (AAH) Drug-Induced ... #diagnosis
Orthopedic Emergencies
Compartment Syndrome
 • An increase in compartment pressure to the point where tissue perfusion is
pressure to the point ... compartment Fat Embolism ... globules in the lung ... • Diagnosis: ... #management #treatment
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... sle #comparison #table ... #rheumatology #diagnosis ... #management
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
association with CTD, drugs ... Organizing Pneumonia - Clinical ... Organizing Pneumonia Treatment ... pulmonary #ILD #diagnosis ... #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... cancer • Septic emboli ... characteristic features Clinical ... Tuberculosis Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... cancer • Septic emboli ... characteristic features Clinical ... Tuberculosis Diagnosis ... #Management #Treatment